Company intelligence / Profile preview

Thirty Madison

New York, New York, United Statesthirtymadison.com ↗

Ownership: Private
Development stage: Commercial

Overview

Thirty Madison operates a commercial-stage virtual care platform offering direct-to-consumer telehealth visits and online prescriptions for chronic conditions. The company has demonstrated significant revenue growth ($100M+ in 2021) and expanded its reach through mergers and new service lines. It is recognized as a unicorn ($1B+ valuation) in digital health.

Therapeutic areas: Men's HealthImmunologyDermatologyGastroenterologyNeurologyWomen's Health
Modalities: DeviceSmall molecule
Industry: Non-Academic Healthcare

Partnerships

Payer partnerships planned/underwayJohnson & Johnson Innovation – JJDC (investor)

Beyond the preview

Go deeper on Thirty Madison.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thirty Madison.

Explore the full profile